Feb. 4 at 4:23 AM
$ACMB multi-billion dollar biotech merger play, this will be one of the biggest OTC stories of 2026.
Stay tuned for LOTS of very impressive DD. The incoming company is targeting a stock price over
$5 by end of this year…current price is just .18 and only a 5.8M float. That is just a
$1M float capitalization, and the float appears to be locked and heavily shorted. Keep watch…